Colorectal cancer in 2017: Practice-changing updates in the adjuvant and metastatic setting

Colorectal cancer in 2017: Practice-changing updates in the adjuvant and metastatic settingColorectal cancer in 2017: Practice-changing updates in the adjuvant and metastatic setting, Published online: 28 November 2017; doi:10.1038/nrclinonc.2017.1852017 has been full of new discoveries that will influence the treatment of colorectal cancer. In the adjuvant setting, 3 months of chemotherapy might now be considered a new standard of care. Various other new treatments and promising biomarkers have also become available that will improve survival outcomes and the quality of life of many patients with metastatic disease.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research